The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma

Clinical trial NCT06609850 · RECRUITING

Trial details

NCT number: NCT06609850
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Recurrent Hepatocellular Carcinoma Lenvatinib Local Therapy Ablation Systemic Therapy

Start date: 2024-10-01
Primary completion: 2026-10-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.